Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C118559 |
1-bromopropane |
1-bromopropane affects the expression of HTR3A mRNA | affects expression | 19576243
|
C045918 |
2-methyl-5-HT |
2-methyl-5-HT binds to and results in increased activity of HTR3A protein | affects binding|increases activity | 15802305
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HTR3A mRNA | affects expression | 16483693
|
D020001 |
1-Butanol |
1-Butanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|increases activity|increases reaction | 17360702
|
D020001 |
1-Butanol |
1-Butanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|increases activity|increases reaction | 17360702
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of HTR3A mRNA | decreases expression | 16644059
|
D003024 |
Clozapine |
Clozapine binds to and results in decreased activity of HTR3A protein | affects binding|decreases activity | 19696922
|
D003024 |
Clozapine |
HTR3A protein affects the susceptibility to Clozapine | affects response to substance | 20168265
|
D003024 |
Clozapine |
Clozapine binds to and results in decreased activity of HTR3A protein | affects binding|decreases activity | 19696922
|
D003976 |
Diazinon |
Diazinon results in increased expression of HTR3A mRNA | increases expression | 18835401
|
D004026 |
Dieldrin |
Dieldrin results in decreased expression of HTR3A mRNA | decreases expression | 18835401
|
D004298 |
Dopamine |
Dopamine binds to and results in increased activity of [HTR3A protein binds to HTR3A protein] | affects binding|increases activity | 17360702
|
D004298 |
Dopamine |
Dopamine binds to and results in increased activity of [HTR3A protein binds to HTR3B protein] | affects binding|increases activity | 17360702
|
D000431 |
Ethanol |
Ethanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|increases activity|increases reaction | 17360702
|
D000431 |
Ethanol |
Ethanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|increases activity|increases reaction | 17360702
|
D000441 |
Hexanols |
Hexanols inhibits the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|decreases reaction|increases activity | 17360702
|
D000441 |
Hexanols |
Hexanols inhibits the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|decreases reaction|increases activity | 17360702
|
D012701 |
Serotonin |
1-Butanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|increases activity|increases reaction | 17360702
|
D012701 |
Serotonin |
1-Butanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|increases activity|increases reaction | 17360702
|
D012701 |
Serotonin |
1-Propanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|increases activity|increases reaction | 17360702
|
D012701 |
Serotonin |
1-Propanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|increases activity|increases reaction | 17360702
|
D012701 |
Serotonin |
Ethanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|increases activity|increases reaction | 17360702
|
D012701 |
Serotonin |
Ethanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|increases activity|increases reaction | 17360702
|
D012701 |
Serotonin |
Hexanols inhibits the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|decreases reaction|increases activity | 17360702
|
D012701 |
Serotonin |
Hexanols inhibits the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|decreases reaction|increases activity | 17360702
|
D012701 |
Serotonin |
Octanols inhibits the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|decreases reaction|increases activity | 17360702
|
D012701 |
Serotonin |
Octanols inhibits the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|decreases reaction|increases activity | 17360702
|
D012701 |
Serotonin |
Pentanols promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|increases activity|increases reaction | 17360702
|
D012701 |
Serotonin |
Pentanols promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|increases activity|increases reaction | 17360702
|
D012701 |
Serotonin |
Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein] | affects binding|increases activity | 17360702
|
D012701 |
Serotonin |
Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein] | affects binding|increases activity | 17360702
|
D008070 |
Lipopolysaccharides |
HTR3A protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] | increases reaction|increases secretion | 15802305
|
D008070 |
Lipopolysaccharides |
HTR3A protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] | increases reaction|increases secretion | 15802305
|
D008070 |
Lipopolysaccharides |
HTR3A protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL8 protein] | increases reaction|increases secretion | 15802305
|
D009532 |
Nickel |
Nickel affects the expression of HTR3A mRNA | affects expression | 18835401
|
D000442 |
Octanols |
Octanols inhibits the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|decreases reaction|increases activity | 17360702
|
D000442 |
Octanols |
Octanols inhibits the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|decreases reaction|increases activity | 17360702
|
D000439 |
Pentanols |
Pentanols promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|increases activity|increases reaction | 17360702
|
D000439 |
Pentanols |
Pentanols promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|increases activity|increases reaction | 17360702
|
D000433 |
1-Propanol |
1-Propanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3A protein]] | affects binding|increases activity|increases reaction | 17360702
|
D000433 |
1-Propanol |
1-Propanol promotes the reaction [Serotonin binds to and results in increased activity of [HTR3A protein binds to HTR3B protein]] | affects binding|increases activity|increases reaction | 17360702
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of HTR3A mRNA | affects cotreatment|decreases expression | 19059307
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HTR3A mRNA | increases expression | 12760830
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of HTR3A mRNA | affects expression | 14699072
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of HTR3A mRNA | affects cotreatment|decreases expression | 19059307
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.47 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
3.83 | 17676605 18926900 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
10.18 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
10.18 | 11192467 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
9.30 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
9.30 | 16166738 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 16712894 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.97 | 14617031 12649775 16160616 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
4.25 | 16487989 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.51 | 17308373 17451421 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.24 | 15451039 15451040 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.52 | 15800139 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.73 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
3.93 | 11141031 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
5.50 | 7820390 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 19184136 |
MESH:D001321 |
Autistic Disorder |
|
Serotonin |
3.47 | 8570775 17157402 18062943 19221690 15132762 18361446 18405062 |
MESH:D001919 |
Bradycardia |
|
Serotonin |
5.39 | 8112388 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.39 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
2.07 | 15770527 11859874 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
2.07 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.07 | 17261762 17893378 16837676 15572757 17049068 15758505 15775269 16912660 17242785 17952589 17440819 17595753 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.07 | 16273361 19142967 17242785 19189210 19115204 18629630 18821012 19189212 19103187 20544844 18425577 19084267 18984771 15668708 20859285 16202921 19200415 18855134 17261762 19011961 17049068 19221464 18997820 15565566 19410462 18815881 16818667 17893378 17440819 20135344 19487384 11161223 19288272 19155303 20390343 18351453 21152245 21138602 20065188 20005174 19289846 16873071 19059307 19244106 19066611 |
MESH:D002056 |
Burns |
|
Ethanol |
4.56 | 16374292 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.69 | 15673190 16192424 15700767 10355542 15721981 16011737 16227642 16124888 3786805 18705752 16050911 16097048 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.42 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.50 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
6.50 | 15763234 18788625 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.50 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.50 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.36 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.23 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.23 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
3.39 | 19332462 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.38 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
2.93 | 19524636 20056578 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Serotonin |
4.13 | 21254450 |
MESH:D021081 |
Chronobiology Disorders |
|
Serotonin |
6.61 | 17157402 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.54 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
3.14 | 15513904 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
11.39 | 17123785 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
11.39 | 15800139 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
2.32 | 11873399 19302082 15451040 15451039 15513904 10194807 11198716 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.28 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.08 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
3.87 | 19470301 17100760 17244072 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.55 | 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
2.95 | 16402076 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.78 | 15920148 17451421 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.78 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Serotonin |
4.68 | 8112388 11488427 10446763 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.47 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
4.03 | 16227642 15027814 9327722 10092053 16177239 15968718 17522070 6623471 7440962 19336974 2869522 7179309 21278145 3786805 4309450 15998439 10915739 3732212 6884620 11566570 19085960 7120509 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
4.03 | 11566570 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.12 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
4.72 | 16487989 |
MESH:D004487 |
Edema |
|
Raloxifene |
7.35 | 15860553 |
MESH:D004487 |
Edema |
|
Serotonin |
7.35 | 18841975 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
8.96 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.96 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
2.99 | 19155303 17893378 20544844 16202921 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.31 | 15821434 17637181 15328337 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
2.73 | 16704527 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
18.16 | 19224547 12795759 61145 15959796 17595544 12631006 16045604 16239168 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
18.16 | 19236843 18620774 16409862 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
18.16 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
18.16 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.58 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.18 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.21 | 16946407 15513904 10194807 15451040 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.93 | 9205823 11852909 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.44 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.10 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.37 | 18705752 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.61 | 15046732 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.47 | 11110106 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.30 | 16366002 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
9.33 | 19110552 19900420 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
9.33 | 16487989 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.77 | 17263646 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.08 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.65 | 18783367 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.45 | 16899240 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.82 | 16046005 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.83 | 15787275 17577099 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.00 | 15338365 |
MESH:D007022 |
Hypotension |
|
Dopamine |
4.93 | 6740701 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
4.85 | 10630421 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
6.94 | 12948887 16466525 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.94 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
8.28 | 9205823 12878042 17255318 17237260 17963957 |
MESH:D007249 |
Inflammation |
|
Nickel |
8.28 | 16166738 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.28 | 19457130 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.55 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
4.32 | 15513904 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.75 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.97 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
4.12 | 15451040 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.41 | 16973256 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.61 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.75 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
7.87 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
7.87 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.65 | 11408273 16221502 16943688 17157831 11903743 17334410 16239168 17174718 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
6.65 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
5.01 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
4.93 | 17761835 14724832 18376398 14716833 17823541 18420326 17481882 12609069 16248980 20821823 16015684 16033810 17708605 16097048 12898905 18395095 17869086 17900296 18472332 11481614 18251166 13678700 18395914 17721639 15818738 18156304 18006644 12445421 18277467 12741479 14620537 18263696 15370692 15123356 12649538 17766677 18472094 18418968 12546737 10355542 17714472 15959796 17805973 15362042 14512876 18339082 12666154 18187930 15673190 17944888 18412020 12632512 12632514 17631135 18210741 16116963 15338365 18705752 15931870 15057751 15730626 15876570 18054572 17525996 17557913 15893842 14748882 16027843 17922224 18279442 16136751 15052691 16638106 17565644 17698563 12958196 12389079 15996030 14716496 18429990 15925388 16011737 12445418 18205269 17976157 17640975 12667390 12586293 18317297 18481824 18166357 16192424 15650968 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
4.93 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
4.93 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.93 | 18564211 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.06 | 17285989 16246199 16964402 15830285 15720792 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.56 | 17347304 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.08 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.61 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
10.50 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
10.50 | 8742319 9539021 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.50 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.50 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
2.56 | 15583823 12014681 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.11 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.92 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.46 | 16712894 19931552 17306315 15276417 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.46 | 18625569 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.67 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.57 | 11731420 19196723 14580682 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.47 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.27 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.27 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.10 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
4.10 | 18411066 15451040 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
3.86 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.34 | 19142101 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.47 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.37 | 16497877 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.47 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.51 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.49 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
5.36 | 8820588 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.36 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.58 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.92 | 19189210 19200415 19196722 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.08 | 12854658 |
MESH:D009765 |
Obesity |
|
Clozapine |
3.00 | 18515891 19142110 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.34 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.14 | 17823083 15579764 15758505 17893378 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.41 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
2.94 | 12384795 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
3.49 | 16112328 17291500 11445065 11181820 16809432 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.47 | 12224865 11605937 |
MESH:D011041 |
Poisoning |
|
Diazinon |
4.27 | 17603234 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.64 | 15731164 16536755 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.64 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.64 | 15067354 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
4.12 | 15331141 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.47 | 15770314 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.67 | 10835634 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
2.72 | 16141801 11763009 19369910 20521326 18806925 17726453 11151749 20107430 17667964 18855531 17123785 20580759 20521320 20452607 20168265 |
MESH:D012640 |
Seizures |
|
Ethanol |
3.11 | 9754883 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.66 | 18572023 19524636 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.21 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.95 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.73 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.30 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.45 | 17189318 17918041 9211565 16755016 9562338 11906479 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.75 | 16837676 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.17 | 9754883 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.08 | 15821434 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.13 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
8.19 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.19 | 16712894 11723127 17306315 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.19 | 16712894 8653321 17572228 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
5.19 | 16487989 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.69 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.13 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.47 | 16343187 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.39 | 20521320 20107430 20564506 17502770 16402076 16141801 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.99 | 17933447 |